Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis ; volume:14 ; number:1 ; day:29 ; month:2 ; year:2016 ; pages:1-5 ; date:12.2016
Pediatric rheumatology ; 14, Heft 1 (29.2.2016), 1-5, 12.2016
- Urheber
-
Scheuern, Andrea
- Beteiligte Personen und Organisationen
-
Fischer, Nadine
McDonald, Joseph
Brunner, Hermine I.
Haas, Johannes-Peter
Hügle, Boris
SpringerLink (Online service)
- DOI
-
10.1186/s12969-016-0071-y
- URN
-
urn:nbn:de:1111-2016030230058
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Scheuern, Andrea
- Fischer, Nadine
- McDonald, Joseph
- Brunner, Hermine I.
- Haas, Johannes-Peter
- Hügle, Boris
- SpringerLink (Online service)
Ähnliche Objekte (12)
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate intolerance in Rheumatoid Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Does caffeine reduce methotrexate intolerance in patients with rheumatoid arthritis: a randomized controlled study
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate intolerance in Rheumatoid Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Does caffeine reduce methotrexate intolerance in patients with rheumatoid arthritis: a randomized controlled study
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate intolerance in Rheumatoid Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Does caffeine reduce methotrexate intolerance in patients with rheumatoid arthritis: a randomized controlled study
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis